{"a": [["Cognition and Type 2 Diabetes \u2013 A pilot randomised controlled trial (RCT) of exercise", "2014"], ["Lifestyle Intervention for Senior Diabetics (LISD)", "2015"], ["Insulin Resistance and Mild Cognitive Impairment (MCI) in Older Chinese Adults With Pre\u2010Diabetes and Diabetes: Cognitive Effects of Lifestyle Intervention and Metformin Treatment in a Randomized Controlled Trial", "2015"], ["A randomised trial comparing low\u2010fat diets differing in carbohydrate and protein ratio, combined with regular moderate intensity exercise, on glycaemic control, cardiometabolic risk factors, food cravings, cognitive function and psychological wellbeing in adults with type 2 diabetes: Study protocol", "2015"], ["Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm \u2013 2017 Executive Summary", "2017"], ["Design of the cooperative study on glycemic controland complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial", "2003"], ["Classification and Diagnosis of Diabetes", "2017"], ["Pharmacologic Approaches to Glycemic Treatment", "2017"], ["Lifestyle Management", "2017"], ["Older Adults", "2017"], ["Glycemic Targets", "2017"], ["American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults", "2012"], ["The pathogenesis of insulin\u2010dependent diabetes mellitus", "1994"], ["Albuminuria and cognitive decline in people with diabetes and normal renal function", "2013"], ["Predictors of cognitive decline in older individuals with diabetes", "2008"], ["Comorbidity and dementia: a scoping review of the literature", "2014"], ["Diabetes as a risk factor for dementia and mild cognitive impairment: a meta\u2010analysis of longitudinal studies", "2012"], ["Glucose levels and risk of dementia", "2013"], ["Cognitive decline and dementia in diabetes\u2014systematic overview of prospective observational studies", "2005"], ["Long\u2010Term Effect of Diabetes and Its Treatment on Cognitive Function", "2007"], ["Alzheimer's disease is type 3 diabetes\u2010evidence reviewed", "2008"], ["Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer\u2019s disease?", "2000"], ["Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM\u20105)", "2013"], ["Diagnostic and Statistical Manual of Mental Disorders", "1994"], ["Glucose control and vascular complications in veterans with type 2 diabetes", "2009"], ["Severe diabetic retinal disease and dementia risk in type 2 diabetes", "2014"], ["Guidance for Industry Alzheimer\u2019s Disease: Developing Drugs for the Treatment of Early Stage Disease", "2013"], ["Is diabetes associated with cognitive impairment and cognitive decline among older women", "2000"], ["GRADE: an emerging consensus on rating quality of evidence and strength of recommendations", "2008"], ["Dementia and Cognitive impairment", "2014"], ["Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future", "2014"], ["The role of cerebral ischemia in Alzheimer\u2019s disease", "2000"], ["Hypertension is related to cognitive impairment a 20 year follow up of 999 men", "1998"], ["Cognitive Dysfunction and Diabetes Mellitus", "2008"], ["Intensive multifactorial treatment and cognitive functioning in screen\u2010detected type 2 diabetes \u2013 the ADDITION\u2010Netherlands study: a cluster\u2010randomized trial", "2012"], ["Dementia update 2003", "2003"], ["Type 2 diabetes in adults: management", "2016"], ["Diabetes mellitus and the risk of dementia: The Rotterdam study", "1999"], ["Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council\u2019s treatment trial of hypertension in older adults", "1996"], ["Use of lipid lowering agents indications bias and the risk of dementia in community dwelling elderly people", "2002"], ["Vascular abnormalities: the insidious pathogenesis of Alzheimer\u2019s disease", "2000"], ["Psychometric limitations of the mini\u2010mental state examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates", "2013"], ["Depression and type 2 diabetes: a causal association?", "2014"], ["Intensive glycaemic control and cognitive decline in patients with type 2 diabetes: a meta\u2010analysis", "2015"], ["Glycemic Control and Health Disparities in Older Ethnically Diverse Underserved Adults With Diabetes Five\u2010year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study", "2011"], ["Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus", "2009"], ["World Health Day 2016: WHO calls for global action to halt rise in and improve care for people with diabetes", "2016"], ["Dementia World Health Organization", "2017"], ["Tracking insulin to the mind", "1998"], ["Pharmacologic Therapy of Type 2 Diabetes", "2016"], ["Accelerated progression from mild cognitive impairment to dementia in people with diabetes", "2010"], ["Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women", "2006"]], "ex": [["Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease", "2010"], ["Effects of basal insulin glargine and omega\u20103 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial", "2014"], ["The effects of progressive resistance training combined with a whey\u2010protein drink and vitamin D supplementation on glycaemic control, body composition and cardiometabolic risk factors in older adults with type 2 diabetes: study protocol for a randomized controlled trial", "2014"], ["Effectiveness of a self\u2010management intervention with personalised genetic and lifestyle\u2010related risk information on coronary heart disease and diabetes\u2010related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial", "2015"], ["Brain and white matter hyperintensity volumes after 10 years of random assignment to lifestyle intervention", "2016"], ["[Effectiveness of cytoflavin for the correction of cognitive impairments in patients with type 2 diabetes mellitus][article in Russian]", "2015"], ["Dietary nitrate supplementation improves reaction time in type 2 diabetes: Development and application of a novel nitrate\u2010depleted beetroot juice placebo", "2014"], ["Verbal learning and/or memory improves with glycemic control in older subjects with non\u2010insulin dependent diabetes mellitus", "1993"], ["Psychosocial and Clinical Outcomes of a Cognitive Behavioral Therapy for Asians and Pacific Islanders with Type 2 Diabetes: A Randomized Clinical Trial", "2015"], ["Improved diabetes control in the elderly delays global cognitive decline", "2011"], ["The effect of improved glycemic control on cognitive functions in the elderly with diabetes", "1993"], ["Cognitive function in elderly non\u2010insulin\u2010dependent diabetic patients before and after inpatient treatment for metabolic control", "1997"], ["Memory Aid by Intranasal Insulin in Diabetes (MemAID) (MemAID)", "2015"], ["Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin (VARQUOGLY)", "2015"], ["HbA1c Variability in Type II Diabetes", "2016"], ["Telemonitoring and Protocolized Case Management for Hypertensive Community\u2010Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial", "2016"], ["Effect of Sancaijiangtang on plasma nitric oxide and endothelin\u20101 levels in patients with type 2 diabetes mellitus and vascular dementia: a single\u2010blind randomized controlled trial", "2015"], ["Ginseng therapy in non\u2010insulin\u2010dependent diabetic patients", "1995"], ["Health economics benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double\u2010blind trial", "1998"], ["Well\u2010being and symptoms in the elderly type 2 diabetes patients with poor metabolic control: effect of insulin treatment.", "1998"], ["Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control", "1999"], ["Supplementation of vitamin e improves cognitive status and oxidative stress in type 2 diabetes mellitus", "2011"], ["Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus", "2016"]], "in": [["Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics", "2006"], ["Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high\u2010risk individuals with type 2 diabetes mellitus Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified\u2010Release Controlled Evaluation", "2001"], ["Long\u2010term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial\u2010\u2010study design, baseline characteristics and effects of intervention", "2012"], ["Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus", "2014"], ["Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open\u2010label substudy", "2011"], ["Improving metabolic control leads to better working memory in adults with type 2 diabetes", "2006"], ["Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial", "2016"]]}